![[pdf]](/display_images/document_icons/pdf.gif){kind=icon}
More about the MS Society
The Multiple Sclerosis Society is a registered charity which was founded in 1953. It relies for its income almost entirely on voluntary donations. Its charitable expenditure in 2002 was more than £26 million.
Since it was founded, the Society has invested more than £50 million in bio-medical and applied research and currently has a £11 million commitment to around 50 projects across the UK.
With the exception of a small number of educational grants amounting to a few thousand pounds, the only income from pharmaceutical companies has been money for their joint funding with the Society and the NHS of specialist MS nurses. This has enabled people with MS to benefit from much needed treatment and multidisciplinary care that they rate very highly.
People affected by MS, those with the condition and their carers, are represented throughout the Society. They are in the majority on its Board of Trustees and play a substantial role at all other levels of its work.
Two examples are the research network of people affected by MS (paMS), which is closely involved in shaping the Society's research strategy and deciding how the Society's funds are spent and monitoring research projects' progress, and the paMS who act as assessors of the Measuring Success scheme, which promotes the highest standards of health and social care delivery. Others include their representation on the Society's public policy forum, the MS Matters editorial board and the committees of more than 350 voluntarily run branches.
Content last updated July 2004 by MS Society Web Team
With the exception of a small number of educational grants amounting to a few thousand pounds, the only income from pharmaceutical companies has been money for their joint funding with the Society and the NHS of specialist MS nurses. This has enabled people with MS to benefit from much needed treatment and multidisciplinary care that they rate very highly.
People affected by MS, those with the condition and their carers, are represented throughout the Society. They are in the majority on its Board of Trustees and play a substantial role at all other levels of its work.
Two examples are the research network of people affected by MS (paMS), which is closely involved in shaping the Society's research strategy and deciding how the Society's funds are spent and monitoring research projects' progress, and the paMS who act as assessors of the Measuring Success scheme, which promotes the highest standards of health and social care delivery. Others include their representation on the Society's public policy forum, the MS Matters editorial board and the committees of more than 350 voluntarily run branches.
Content last updated July 2004 by MS Society Web Team
